JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

Search

VistaGen Therapeutics Inc

Închisă

0.56

Rezumat

Modificarea prețului

24h

Curent

Minim

0.55

Maxim

0.59

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+73.21% upside

Dividende

By Dow Jones

Următoarele câștiguri

12 feb. 2026

VistaGen Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 feb. 2026, 23:26 UTC

Principalele dinamici ale pieței

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

10 feb. 2026, 22:31 UTC

Câștiguri

Correction to America Movil 4Q Profit Article

10 feb. 2026, 22:22 UTC

Câștiguri

America Movil 4Q Profit Jumps on Lower Financial Costs

10 feb. 2026, 23:51 UTC

Market Talk
Câștiguri

Commonwealth Bank's Margin Management Gives It a Platform -- Market Talk

10 feb. 2026, 23:42 UTC

Market Talk

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

10 feb. 2026, 23:40 UTC

Market Talk
Câștiguri

Commonwealth Bank Bear Says 1H Result Looks Strong -- Market Talk

10 feb. 2026, 23:21 UTC

Market Talk

Ford Says EV Shift Was Driven by Demand Changes -- Market Talk

10 feb. 2026, 23:21 UTC

Market Talk

Global Equities Roundup: Market Talk

10 feb. 2026, 22:17 UTC

Market Talk

Australia's One Nation Now Commands Working Class Vote -- Market Talk

10 feb. 2026, 22:15 UTC

Câștiguri

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

10 feb. 2026, 22:10 UTC

Câștiguri

Intact Financial 4Q Book Value Per Share Was C$107.35 >IFC.T

10 feb. 2026, 22:10 UTC

Câștiguri

Intact Financial Raises Qtr Dividend to C$1.47 >IFC.T

10 feb. 2026, 22:09 UTC

Câștiguri

Intact Financial 4Q Combined Ratio Was 85.9% >IFC.T

10 feb. 2026, 22:09 UTC

Câștiguri

Intact Financial 4Q Adj EPS C$5.50 >IFC.T

10 feb. 2026, 22:01 UTC

Câștiguri

Intact Financial 4Q EPS C$5.24 >IFC.T

10 feb. 2026, 21:54 UTC

Câștiguri

James Hardie Industries Sees FY26 Total Adjusted EBITDA $1.232B to $1.263B >JHX

10 feb. 2026, 21:53 UTC

Câștiguri

Robinhood Stock Tumbles as Crypto-Related Revenue Falls Short of Expectations -- Barrons.com

10 feb. 2026, 21:51 UTC

Câștiguri

James Hardie Industries Sees FY26 Free Cash Flow at Least $200M

10 feb. 2026, 21:51 UTC

Câștiguri

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 feb. 2026, 21:51 UTC

Câștiguri

James Hardie Industries: Focused on the Achievement of $125 M Target >JHX

10 feb. 2026, 21:51 UTC

Câștiguri

James Hardie Industries: Integration and Cost Synergies Ahead of Schedule >JHX

10 feb. 2026, 21:51 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Evolution Net Debt A$362 Million at Dec. 31 Vs A$1.29 Billion Year Earlier

10 feb. 2026, 21:50 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Evolution: Gearing 6% at Dec. 31, From 23% a Year Earlier

10 feb. 2026, 21:50 UTC

Câștiguri

James Hardie Industries 3Q EPS 12c >JHX

10 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 feb. 2026, 21:50 UTC

Câștiguri

James Hardie Industries 3Q Adj EPS 24c >JHX

10 feb. 2026, 21:49 UTC

Câștiguri

James Hardie Industries 3Q Sales $1.24B >JHX

10 feb. 2026, 21:49 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Evolution 1H Operating Mine Cash Flow a Record A$1.73 Billion

10 feb. 2026, 21:48 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Evolution 1H Ebitda A$1.56 Billion, Up 59% On-Year

10 feb. 2026, 21:47 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Evolution 1H Revenue A$2.79 Billion, Up 37% On-Year

Comparație

Modificare preț

VistaGen Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

73.21% sus

Prognoză pe 12 luni

Medie 0.97 USD  73.21%

Maxim 1 USD

Minim 0.9 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruVistaGen Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

5 ratings

0

Cumpărare

5

Păstrare

0

Vânzare

Date financiare

$

help-icon Live chat